Clinical Trial Update: Automated Insulin Delivery for Inpatients With Dysglycemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from Emory University evaluating automated insulin delivery for inpatients with dysglycemia has completed. Results are not provided in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Emory University | Conditions: Type 1 Diabetes, Type 2 Diabetes | Phase 3 | Status: COMPLETED